Pages that link to "Q37037294"

The following pages link to Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia (Q37037294):

Displaying 44 items.

• Pharmacological targeting of PI3K isoforms as a therapeutic strategy in chronic lymphocytic leukaemia (Q26779129) (← links)
• The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia (Q27024411) (← links)
• Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia (Q28087672) (← links)
• Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignancies (Q33433009) (← links)
• Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma (Q33567169) (← links)
• Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL. (Q34047852) (← links)
• Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia (Q34997508) (← links)
• Invention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor. (Q35962099) (← links)
• Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution (Q36392470) (← links)
• Evolution and impact of subclonal mutations in chronic lymphocytic leukemia (Q36619124) (← links)
• Phosphoinositide 3'-kinase inhibition in chronic lymphocytic leukemia (Q36737287) (← links)
• Genomic approaches to chronic lymphocytic leukemia (Q36737322) (← links)
• Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia. (Q36799831) (← links)
• Small lymphocytic lymphoma/chronic lymphocytic leukemia with chromothripsis in an old woman (Q36804921) (← links)
• Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition (Q36925503) (← links)
• Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics (Q36998431) (← links)
• Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future (Q37073888) (← links)
• Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma (Q37497233) (← links)
• Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations (Q37697093) (← links)
• Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness (Q37697850) (← links)
• Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies (Q38061177) (← links)
• Chronic lymphocytic leukemia: Time to go past genomics? (Q38708220) (← links)
• Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups (Q38742049) (← links)
• Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia (Q38744632) (← links)
• Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia. (Q38818283) (← links)
• Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Q38896306) (← links)
• Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma (Q39008207) (← links)
• Characterization and analysis of the composition and dynamics of the mammalian riboproteome. (Q39093565) (← links)
• The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells. (Q40575812) (← links)
• Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort (Q40880741) (← links)
• Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation (Q42208521) (← links)
• PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma (Q42371625) (← links)
• Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia. (Q44447816) (← links)
• MYC addiction in chronic lymphocytic leukemia (Q44879882) (← links)
• Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. (Q44882002) (← links)
• CLL/SLL diagnosed in an adolescent (Q45783720) (← links)
• Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study (Q50532164) (← links)
• FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia. (Q50621489) (← links)
• Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial. (Q52725994) (← links)
• Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib (Q58729853) (← links)
• Is There a Role for Dual PI3K/mTOR Inhibitors for Patients Affected with Lymphoma? (Q89599313) (← links)
• Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia (Q90024786) (← links)
• Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors (Q90744809) (← links)
• The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer (Q91982061) (← links)